{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:17:33Z","timestamp":1776262653711,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T00:00:00Z","timestamp":1221004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T00:00:00Z","timestamp":1221004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Systemic lupus erythematosus is a genetically complex disease. Currently, the precise allelic polymorphisms associated with this condition remain largely unidentified. In part this reflects the fact that multiple genes, each having a relatively minor effect, act in concert to produce disease. Given this complexity, analysis of subclinical phenotypes may aid in the identification of susceptibility alleles. Here, we used flow cytometry to investigate whether some of the immune abnormalities that are seen in the peripheral blood lymphocyte population of lupus patients are seen in their first-degree relatives.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Peripheral blood mononuclear cells were isolated from the subjects, stained with fluorochrome-conjugated monoclonal antibodies to identify various cellular subsets, and analyzed by flow cytometry.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>We found reduced proportions of natural killer (NK)T cells among 367 first-degree relatives of lupus patients as compared with 102 control individuals. There were also slightly increased proportions of memory B and T cells, suggesting increased chronic low-grade activation of the immune system in first-degree relatives. However, only the deficiency of NKT cells was associated with a positive anti-nuclear antibody test and clinical autoimmune disease in family members. There was a significant association between mean parental, sibling, and proband values for the proportion of NKT cells, suggesting that this is a heritable trait.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The findings suggest that analysis of cellular phenotypes may enhance the ability to detect subclinical lupus and that genetically determined altered immunoregulation by NKT cells predisposes first-degree relatives of lupus patients to the development of autoimmunity.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2505","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T18:13:34Z","timestamp":1221070414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity"],"prefix":"10.1186","volume":"10","author":[{"given":"Joan","family":"Wither","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-chun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooyeol","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Roslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime O","family":"Claudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glinda S","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia MT","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafna","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Douglas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Hanly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Peschken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Boire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"CaNIOS Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,10]]},"reference":[{"key":"2354_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.immunol.16.1.261","volume":"16","author":"TJ Vyse","year":"1998","unstructured":"Vyse TJ, Kotzin BL: Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol. 1998, 16: 261-292.","journal-title":"Annu Rev Immunol"},{"key":"2354_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","volume":"15","author":"EK Wakeland","year":"2001","unstructured":"Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001, 15: 397-408.","journal-title":"Immunity"},{"key":"2354_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.rdc.2005.01.005","volume":"31","author":"AL Sestak","year":"2005","unstructured":"Sestak AL, Nath SK, Harley JB: Genetics of systemic lupus erythematosus: how far have we come?. Rheum Dis Clin North Am. 2005, 31: 223-244.","journal-title":"Rheum Dis Clin North Am"},{"key":"2354_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ng.81","volume":"40","author":"JB Harley","year":"2008","unstructured":"Harley JB, arcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD: Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008, 40: 204-210.","journal-title":"Nat Genet"},{"key":"2354_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMoa0707865","volume":"358","author":"G Hom","year":"2008","unstructured":"Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA, Gregersen PK, Behrens TW: Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008, 358: 900-909.","journal-title":"N Engl J Med"},{"key":"2354_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(06)92001-X","volume":"92","author":"AM Fairhurst","year":"2006","unstructured":"Fairhurst AM, Wandstrat AE, Wakeland EK: Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol. 2006, 92: 1-69.","journal-title":"Adv Immunol"},{"key":"2354_CR7","first-page":"207","volume":"53","author":"T Henry","year":"2005","unstructured":"Henry T, Mohan C: Systemic lupus erythematosus: recent clues from congenic strains. Arch Immunol Ther Exp (Warsz). 2005, 53: 207-212.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2354_CR8","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.4049\/jimmunol.171.4.1697","volume":"171","author":"JE Wither","year":"2003","unstructured":"Wither JE, Lajoie G, Heinrichs S, Cai YC, Chang N, Ciofani A, Cheung YH, MacLeod R: Functional dissection of lupus susceptibility loci on the New Zealand black mouse chromosome 1: evidence for independent genetic loci affecting T and B cell activation. J Immunol. 2003, 171: 1697-1706.","journal-title":"J Immunol"},{"key":"2354_CR9","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.4049\/jimmunol.175.7.4309","volume":"175","author":"JE Wither","year":"2005","unstructured":"Wither JE, Loh C, Lajoie G, Heinrichs S, Cai YC, Bonventi G, MacLeod R: Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol. 2005, 175: 4309-4319.","journal-title":"J Immunol"},{"key":"2354_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1191\/0961203304lu2015oa","volume":"13","author":"H Laustrup","year":"2004","unstructured":"Laustrup H, Heegaard NH, Voss A, Green A, Lillevang ST, Junker P: Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus. 2004, 13: 792-799.","journal-title":"Lupus"},{"key":"2354_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/096120339300200303","volume":"2","author":"S Miles","year":"1993","unstructured":"Miles S, Isenberg D: A review of serological abnormalities in relatives of SLE patients. Lupus. 1993, 2: 145-150.","journal-title":"Lupus"},{"issue":"suppl 1","key":"2354_CR12","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1038\/sj.gene.6363905","volume":"3","author":"B Namjou","year":"2002","unstructured":"Namjou B, Nath SK, Kilpatrick J, Kelly JA, Reid J, Reichlin M, James JA, Harley JB: Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2). Genes Immun. 2002, 3 (suppl 1): S35-S41.","journal-title":"Genes Immun"},{"key":"2354_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.gene.6364316","volume":"7","author":"PS Ramos","year":"2006","unstructured":"Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM, Namjou B, Espe KJ, Ortmann WA, Reichlin M, Langefeld CD, James JA, Gaffney PM, Behrens TW, Harley JB, Moser KL: Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun. 2006, 7: 417-432.","journal-title":"Genes Immun"},{"key":"2354_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2249.1998.00533.x","volume":"111","author":"T Bourne","year":"1998","unstructured":"Bourne T, Zukowska-Cooper M, Salaman MR, Seifert MH, Isenberg DA: Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38. Clin Exp Immunol. 1998, 111: 611-616.","journal-title":"Clin Exp Immunol"},{"key":"2354_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/art.1780310112","volume":"31","author":"T Sakane","year":"1988","unstructured":"Sakane T, Suzuki N, Takada S, Ueda Y, Murakawa Y, Tsuchida T, Yamauchi Y, Kishimoto T: B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1988, 31: 80-87.","journal-title":"Arthritis Rheum"},{"key":"2354_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/clin.1997.4353","volume":"83","author":"D Folzenlogen","year":"1997","unstructured":"Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK: Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol. 1997, 83: 199-204.","journal-title":"Clin Immunol Immunopathol"},{"key":"2354_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1365-2249.1996.44754.x","volume":"104","author":"PE Spronk","year":"1996","unstructured":"Spronk PE, Horst G, Gun Van Der BT, Limburg PC, Kallenberg CG: Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Clin Exp Immunol. 1996, 104: 446-453.","journal-title":"Clin Exp Immunol"},{"key":"2354_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2249.2001.01623.x","volume":"125","author":"JF Viallard","year":"2001","unstructured":"Viallard JF, Bloch-Michel C, Neau-Cransac M, Taupin JL, Garrigue S, Miossec V, Mercie P, Pellegrin JL, Moreau JF: HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol. 2001, 125: 485-491.","journal-title":"Clin Exp Immunol"},{"key":"2354_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/ard.60.5.523","volume":"60","author":"M Bijl","year":"2001","unstructured":"Bijl M, Horst G, Limburg PC, Kallenberg CG: Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis. 2001, 60: 523-526.","journal-title":"Ann Rheum Dis"},{"key":"2354_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/096120339700600507","volume":"6","author":"CC Su","year":"1997","unstructured":"Su CC, Shau WY, Wang CR, Chuang CY, Chen CY: CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity. Lupus. 1997, 6: 449-454.","journal-title":"Lupus"},{"key":"2354_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4049\/jimmunol.180.2.1276","volume":"180","author":"NH Chang","year":"2008","unstructured":"Chang NH, McKenzie T, Bonventi G, Landolt-Marticorena C, Fortin PR, Gladman D, Urowitz M, Wither JE: Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus. J Immunol. 2008, 180: 1276-1284.","journal-title":"J Immunol"},{"key":"2354_CR22","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1002\/art.20592","volume":"50","author":"JH Anolik","year":"2004","unstructured":"Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I: Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 3580-3590.","journal-title":"Arthritis Rheum"},{"key":"2354_CR23","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.4049\/jimmunol.167.4.2361","volume":"167","author":"E Arce","year":"2001","unstructured":"Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V: Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol. 2001, 167: 2361-2369.","journal-title":"J Immunol"},{"key":"2354_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W","volume":"44","author":"S Kojo","year":"2001","unstructured":"Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T: Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001, 44: 1127-1138.","journal-title":"Arthritis Rheum"},{"key":"2354_CR25","first-page":"275","volume":"28","author":"Y Oishi","year":"2001","unstructured":"Oishi Y, Sumida T, Sakamoto A, Kita Y, Kurasawa K, Nawata Y, Takabayashi K, Takahashi H, Yoshida S, Taniguchi M, Saito Y, Iwamoto I: Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2001, 28: 275-283.","journal-title":"J Rheumatol"},{"key":"2354_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/08830180500544480","volume":"25","author":"HK Kang","year":"2006","unstructured":"Kang HK, Datta SK: Regulatory T cells in lupus. Int Rev Immunol. 2006, 25: 5-25.","journal-title":"Int Rev Immunol"},{"key":"2354_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/ard.2005.044974","volume":"65","author":"S Mellor-Pita","year":"2006","unstructured":"Mellor-Pita S, Citores MJ, Castejon R, Tutor-Ureta P, Yebra-Bango M, Andreu JL, Vargas JA: Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis. 2006, 65: 553-554.","journal-title":"Ann Rheum Dis"},{"key":"2354_CR28","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","volume":"175","author":"M Miyara","year":"2005","unstructured":"Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G: Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol. 2005, 175: 8392-8400.","journal-title":"J Immunol"},{"key":"2354_CR29","first-page":"351","volume":"37","author":"PH van Elteren","year":"1960","unstructured":"van Elteren PH: On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst. 1960, 37: 351-361.","journal-title":"Bull Int Stat Inst"},{"key":"2354_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1034\/j.1399-0039.2002.590501.x","volume":"59","author":"KJ Hammond","year":"2002","unstructured":"Hammond KJ, Godfrey DI: NKT cells: potential targets for autoimmune disease therapy?. Tissue Antigens. 2002, 59: 353-363.","journal-title":"Tissue Antigens"},{"key":"2354_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.humimm.2006.02.020","volume":"66","author":"L Linsen","year":"2005","unstructured":"Linsen L, Somers V, Stinissen P: Immunoregulation of autoimmunity by natural killer T cells. Hum Immunol. 2005, 66: 1193-1202.","journal-title":"Hum Immunol"},{"key":"2354_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.imlet.2005.06.010","volume":"100","author":"KO Yu","year":"2005","unstructured":"Yu KO, Porcelli SA: The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol Lett. 2005, 100: 42-55.","journal-title":"Immunol Lett"},{"key":"2354_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI0213605","volume":"109","author":"A Kukreja","year":"2002","unstructured":"Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002, 109: 131-140.","journal-title":"J Clin Invest"},{"key":"2354_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997, 84: 223-243.","journal-title":"Clin Immunol Immunopathol"},{"key":"2354_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/jaut.1996.0008","volume":"9","author":"J Clark","year":"1996","unstructured":"Clark J, Bourne T, Salaman MR, Seifert MH, Isenberg DA: B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus. J Autoimmun. 1996, 9: 59-65.","journal-title":"J Autoimmun"},{"key":"2354_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2249.2005.02822.x","volume":"141","author":"MR Green","year":"2005","unstructured":"Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR: Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol. 2005, 141: 165-173.","journal-title":"Clin Exp Immunol"},{"key":"2354_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/art.22326","volume":"56","author":"MR Green","year":"2007","unstructured":"Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR: Natural killer T cells in families of patients with systemic lupus erythematosus: Their possible role in regulation of IGG production. Arthritis Rheum. 2007, 56: 303-310.","journal-title":"Arthritis Rheum"},{"key":"2354_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02647.x","volume":"122","author":"CJ Montoya","year":"2007","unstructured":"Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB: Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 2007, 122: 1-14.","journal-title":"Immunology"},{"key":"2354_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/sj.gene.6364453","volume":"9","author":"DS Graham","year":"2008","unstructured":"Graham DS, Vyse TJ, Fortin PR, Montpetit A, Cai YC, Lim S, McKenzie T, Farwell L, Rhodes B, Chad L, Hudson TJ, Sharpe A, Terhorst C, Greenwood CM, Wither J, Rioux JD: Association of LY9 in UK and Canadian SLE families. Genes Immun. 2008, 9: 93-102.","journal-title":"Genes Immun"},{"key":"2354_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/clim.2001.5060","volume":"100","author":"V van d","year":"2001","unstructured":"van d V, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, Polman CH, Rustemeyer T, Lips P, Eertwegh van den AJ, Giaccone G, Scheper RJ, Pinedo HM: Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001, 100: 144-148.","journal-title":"Clin Immunol"},{"key":"2354_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.182.4.1163","volume":"182","author":"T Sumida","year":"1995","unstructured":"Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S, Nishioka K, Iwamoto I, Taniguchi M: Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med. 1995, 182: 1163-1168.","journal-title":"J Exp Med"},{"key":"2354_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.01018.x","volume":"118","author":"Y Yanagihara","year":"1999","unstructured":"Yanagihara Y, Shiozawa K, Takai M, Kyogoku M, Shiozawa S: Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 1999, 118: 131-136.","journal-title":"Clin Exp Immunol"},{"key":"2354_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/intimm\/dxg029","volume":"15","author":"M Araki","year":"2003","unstructured":"Araki M, Kondo T, Gumperz JE, Brenner MB, Miyake S, Yamamura T: Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol. 2003, 15: 279-288.","journal-title":"Int Immunol"},{"key":"2354_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/34419","volume":"391","author":"SB Wilson","year":"1998","unstructured":"Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 1998, 391: 177-181.","journal-title":"Nature"},{"key":"2354_CR45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.187.7.1047","volume":"187","author":"KJ Hammond","year":"1998","unstructured":"Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG: alpha\/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)\/Lt mice by the influence of interleukin (IL)-4 and\/or IL-10. J Exp Med. 1998, 187: 1047-1056.","journal-title":"J Exp Med"},{"key":"2354_CR46","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nm0901-1057","volume":"7","author":"S Sharif","year":"2001","unstructured":"Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A: Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med. 2001, 7: 1057-1062.","journal-title":"Nat Med"},{"key":"2354_CR47","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1073\/pnas.121169698","volume":"98","author":"FD Shi","year":"2001","unstructured":"Shi FD, Flodstrom M, Balasa B, Kim SH, Van GK, Strominger JL, Wilson SB, Sarvetnick N: Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci USA. 2001, 98: 6777-6782.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2354_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.194.3.313","volume":"194","author":"B Wang","year":"2001","unstructured":"Wang B, Geng YB, Wang CR: CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med. 2001, 194: 313-320.","journal-title":"J Exp Med"},{"key":"2354_CR49","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1084\/jem.194.12.1801","volume":"194","author":"AK Singh","year":"2001","unstructured":"Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van KL: Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001, 194: 1801-1811.","journal-title":"J Exp Med"},{"key":"2354_CR50","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.1073\/pnas.92.25.11931","volume":"92","author":"T Yoshimoto","year":"1995","unstructured":"Yoshimoto T, Bendelac A, Hu-Li J, Paul WE: Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci USA. 1995, 92: 11931-11934.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2354_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/art.11489","volume":"50","author":"A Chiba","year":"2004","unstructured":"Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S: Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004, 50: 305-313.","journal-title":"Arthritis Rheum"},{"key":"2354_CR52","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.156.10.4035","volume":"156","author":"MA Mieza","year":"1996","unstructured":"Mieza MA, Itoh T, Cui JQ, Makino Y, Kawano T, Tsuchida K, Koike T, Shirai T, Yagita H, Matsuzawa A, Koseki H, Taniguchi M: Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol. 1996, 156: 4035-4040.","journal-title":"J Immunol"},{"key":"2354_CR53","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.4049\/jimmunol.171.8.4439","volume":"171","author":"JQ Yang","year":"2003","unstructured":"Yang JQ, Saxena V, Xu H, Van KL, Wang CR, Singh RR: Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr\/lpr mice. J Immunol. 2003, 171: 4439-4446.","journal-title":"J Immunol"},{"key":"2354_CR54","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4049\/jimmunol.175.2.763","volume":"175","author":"C Forestier","year":"2005","unstructured":"Forestier C, Molano A, Im JS, Dutronc Y, Diamond B, Davidson A, Illarionov PA, Besra GS, Porcelli SA: Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black \u00d7 New Zealand White)F1 mice. J Immunol. 2005, 175: 763-770.","journal-title":"J Immunol"},{"key":"2354_CR55","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.4049\/jimmunol.164.10.5000","volume":"164","author":"D Zeng","year":"2000","unstructured":"Zeng D, Lee MK, Tung J, Brendolan A, Strober S: Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB\/NZW mice. J Immunol. 2000, 164: 5000-5004.","journal-title":"J Immunol"},{"key":"2354_CR56","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1172\/JCI200317165","volume":"112","author":"D Zeng","year":"2003","unstructured":"Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S: Activation of natural killer T cells in NZB\/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest. 2003, 112: 1211-1222.","journal-title":"J Clin Invest"},{"key":"2354_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/eji.200425861","volume":"35","author":"AK Singh","year":"2005","unstructured":"Singh AK, Yang JQ, Parekh VV, Wei J, Wang CR, Joyce S, Singh RR, Van KL: The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur J Immunol. 2005, 35: 1143-1154.","journal-title":"Eur J Immunol"},{"key":"2354_CR58","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/art.21056","volume":"52","author":"A Chiba","year":"2005","unstructured":"Chiba A, Kaieda S, Oki S, Yamamura T, Miyake S: The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum. 2005, 52: 1941-1948.","journal-title":"Arthritis Rheum"},{"key":"2354_CR59","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1084\/jem.194.12.1789","volume":"194","author":"AW Jahng","year":"2001","unstructured":"Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V: Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med. 2001, 194: 1789-1799.","journal-title":"J Exp Med"},{"key":"2354_CR60","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/35097097","volume":"413","author":"K Miyamoto","year":"2001","unstructured":"Miyamoto K, Miyake S, Yamamura T: A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 2001, 413: 531-534.","journal-title":"Nature"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2505\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:34:05Z","timestamp":1728383645000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,10]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,10]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1186\/ar2505","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,10]]},"assertion":[{"value":"10 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R108"}}